Results 71 to 80 of about 9,904 (185)

An Audio-Based Method for Assessing Proper Usage of Dry Powder Inhalers

open access: yesApplied Sciences, 2020
Critical technique errors are very often performed by patients in the use of Dry Powder Inhalers (DPIs) resulting in a reduction of the clinical efficiency of such medication.
Athina-Chara Eleftheriadou   +4 more
doaj   +1 more source

An in vitro aerosolization efficiency comparison of generic and branded salbutamol metered dose inhalers [PDF]

open access: yes, 2017
Background: Due to the high rate of pulmonary diseases, respiratory drug delivery systems have been attracted excessive attention for the past decades.
Ghanbarzadeh, Saeed   +3 more
core   +2 more sources

Dry powder inhalation, part 2

open access: yesExpert Opinion on Drug Delivery, 2022
Introduction: The manufacture of modern dry powder inhalers (DPIs), starting with the Spinhaler (Fisons) in 1967, was only possible thanks to a series of technological developments in the 20th century, of which many started first around 1950. Not until then, it became possible to design and develop effective, cheap and mass-produced DPIs.
de Boer, Anne Haaije   +2 more
openaire   +1 more source

The crucial role of leucine concentration on spray dried mannitol-leucine as a single carrier to enhance the aerosolization performance of Albuterol sulfate [PDF]

open access: yes, 2018
Generally, DPI formulations show low fine particle fraction (FPF) due to poor detachment of drug particles from carrier during inhalation. L-Leucine, with varying concentrations (ranging from 0 to 10% w/w), were introduced into a 60%w/v mannitol solution
Adia   +42 more
core   +2 more sources

ADVANCEMENTS IN DRY POWDER INHALER

open access: yesAsian Journal of Pharmaceutical and Clinical Research, 2017
The dry powder inhaler (DPI) has become widely known as a very attractive platform for drug delivery. DPIs are being used for the treatment of asthma and chronic obstructive pulmonary disease by many patients. There are over 20 devices presently in the DPI market. DPIs are preferred over nebulizers and pressurized metered dose inhalers.
Ganga Srinivasan, Advait Shetty
openaire   +2 more sources

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]

open access: yes, 2014
BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...
Aalbers   +511 more
core   +1 more source

Does size really matter:relationship of particle size to lung deposition and exhaled fraction [PDF]

open access: yes, 2017
We demonstrate that extra-fine particles are not associated with an appreciably higher exhaled fraction, hence explaining their efficacy profile in asthma.
Brian Lipworth   +12 more
core   +2 more sources

Dry Powder Inhalation of siRNA [PDF]

open access: yesTherapeutic Delivery, 2019
Keil, Tobias WM, Merkel, Olivia M
openaire   +2 more sources

[New dry powder inhalers].

open access: yesPneumonologia i alergologia polska, 2016
The most recently approved DPI's - Ellipta™ and NEXThaler® are the most modern inhalers on the market. Both are flow independent in the physiological range of flows seen in patients with asthma and/or COPD. Both require three actions (open-load -inhaler) for a successful inhalation.
Andrzej, Emeryk, Michał, Pirożyński
openaire   +1 more source

Home - About - Disclaimer - Privacy